Oncogenomics

This transformation is determined by both inherited genetic factors and somatic genetic alterations and mutations, and it results in uncontrolled cell growth and leads to death. The genetic mutations that lead to cancer occur only in certain genes. Cancer-causing genes have been classified as proto-oncogenes (e.g., the genes for MYC, ERBB2 and EGFR) and tumor suppressor genes such as the genes that encode TP53, CDKN2A, and RB.

The completion of the Human Genome Project simplified the field of oncogenomic and improved the abilities of researchers to find oncogenes. Sequencing technologies and global methylation profiling methods are practiced to the study of oncogenomics.

 

  • human chromosome 17
  • lipophilin B
  • mammaglobin gene

Related Conference of Oncogenomics

September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
October 05-06, 2026

22nd International Conference on Cancer Research

Madrid, Spain
November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands

Oncogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in